
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dr Reddy's Laboratories (NYSE:RDY) through any online brokerage.
Other companies in Dr Reddy's Laboratories’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Dr Reddy's Laboratories has a consensus price target of $494.63.
The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $12.32 last updated October 5, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Dr Reddy's Laboratories.
Dr Reddy's Laboratories does not have any upcoming earnings scheduled.
There is no upcoming split for Dr Reddy's Laboratories.
Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond...